Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.58 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11611701 | 0.88 | OPRM1 (0.58) | TSHROPRM1OPRL1SMN1; SMN2HPGD | |
| SCHEMBL14964721 | 0.86 | TSHR (0.54) | TSHROPRM1OPRL1SMN1; SMN2HPGD | |
| SCHEMBL3229771 | 0.85 | OPRM1 (0.55) | TSHROPRM1OPRL1SMN1; SMN2HPGD | |
| SCHEMBL11565084 | 0.85 | OPRM1 (0.55) | TSHROPRM1OPRL1SMN1; SMN2HPGD | |
| SCHEMBL17342633 | 0.83 | ALDH1A1 (0.46) | TSHROPRM1OPRL1SMN1; SMN2HPGD | |
| SCHEMBL23686835 | 0.83 | NPC1 (0.62) | OPRM1OPRL1HPGDKMT2AMEN1 | |
| SCHEMBL4428204 | 0.83 | KMT2A (0.66) | TSHRKMT2AMEN1ALDH1A1 | |
| SCHEMBL9354299 | 0.83 | OPRM1 (0.54) | TSHROPRM1OPRL1SMN1; SMN2HPGD | |
| SCHEMBL4508687 | 0.82 | TSHR (0.63) | TSHROPRM1OPRL1SMN1; SMN2HPGD | |
| SCHEMBL16994790 | 0.82 | TSHR (0.63) | TSHRSMN1; SMN2HPGDKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114621560-A | Thermosetting resin composition, prepreg, fiber-reinforced plastic molded article, and method for producing same | 三菱化学株式会社 | 2022-06-14 | — | — | CN | claimed |
| CN-110637041-B | Epoxy resin composition for fiber-reinforced composite material and fiber-reinforced composite material | 东丽株式会社 | 2022-05-10 | — | — | CN | claimed |
| CN-111278886-A | Thermosetting resin composition, prepreg, fiber-reinforced composite material, and method for producing same | 三菱化学株式会社 | 2020-06-12 | — | — | CN | claimed |
| CN-110637041-A | Epoxy resin composition for fiber-reinforced composite material and fiber-reinforced composite material | 东丽株式会社 | 2019-12-31 | — | — | CN | claimed |
| CN-107573649-A | A kind of fast curing prepreg epoxy-resin systems and preparation method thereof | 襄阳金华联航空科技有限公司 | 2018-01-12 | — | — | CN | claimed |
| US-8729089-B2 | Pyrido(3,2-d)pyrimidines useful for treating viral infections | GILEAD SCIENCES, INC. (US) | 2014-05-20 | — | — | US | claimed |
| CN-114746483-B | Resin composition for sheet molding compound, molded article, and method for producing sheet molding compound | DIC株式会社 | 2024-06-25 | — | — | CN | disclosed |
| CN-118019785-A | Method for producing prepreg and prepreg | 三菱化学株式会社 | 2024-05-10 | — | — | CN | disclosed |
| CN-112839977-B | Prepreg, fiber-reinforced composite resin molded body, method for producing tubular molded body, epoxy resin composition, and tubular molded body | 三菱化学株式会社 | 2024-02-13 | — | — | CN | disclosed |
| CN-117355563-A | Self-assembled carbon fiber bundle and method for producing same, and prepreg and method for producing same | 三菱化学株式会社 | 2024-01-05 | — | — | CN | disclosed |
| CN-117242134-A | Curable resin composition | 三键有限公司 | 2023-12-15 | — | — | CN | disclosed |
| CN-117164914-A | Prepreg and fiber-reinforced composite resin molded article | 三菱化学株式会社 | 2023-12-05 | — | — | CN | disclosed |
| CN-116981721-A | Resin composition, prepreg and fiber-reinforced plastic | 三菱化学株式会社 | 2023-10-31 | — | — | CN | disclosed |
| US-20080027093-A1 | Cyclohexylalanine Derivatives as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes | MERCK SHARP & DOHME LLC | 2008-01-31 | — | — | US | disclosed |
| CN-1301981-C | Medicinal composition containing 1,3-thiazine derivative | SHIONOGI & CO (JP) | 2007-02-28 | — | — | CN | disclosed |
| US-7053138-B2 | Flame-proofing agents | HUNTSMAN ADVANCED MATERIALS AMERICAS INC. (US) | 2006-05-30 | — | — | US | disclosed |
| CN-1247553-C | 2-imino-1,3-thiazine derivs. | SHIONOGI & CO (JP) | 2006-03-29 | — | — | CN | disclosed |
| WO-2006005559-A1 | STABLE CURABLE EPOXY RESIN COMPOSITIONS AND USES THEREOF | HEXION SPECIALTY CHEMICALS RESEARCH BELGIUM S.A. (BE) | 2006-01-19 | — | — | WO | disclosed |
| CN-1514831-A | Medicinal composition containing 1,3-thiazine derivative | ��Ұ����ҩ��ʽ���� | 2004-07-21 | — | — | CN | disclosed |
| CN-1387519-A | 2-imino-1, 3-thiazine derivatives | SHIONOGI & CO (JP) | 2002-12-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080027093-A1 | Cyclohexylalanine Derivatives as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes | DPP4, DPP3, DPP7 | TSHR 4219/4885OPRM1 3620/4885OPRL1 2004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.